Hospital
County of Los Angeles
County of Los Angeles was paid $1.30M by Medicaid between Jan 2018 and Dec 2024, across 219 billing codes. Its largest line is 0510, — 59% of everything it billed.
33Billing provider infoCOUNTY OF LOS ANGELES
DOWNEY, CA 90242
DOWNEY, CA 90242
33aNPI1447460977assigned 05/23/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.30M
24GClaims439,155
24DCodes billed219
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#263 of 410
Median peer was paid$6.90M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,509 | $0.00 | |
| 2019 | 39,300 | $12K | |
| 2020 | 44,188 | $130K | |
| 2021 | 69,135 | $242K | |
| 2022 | 74,162 | $313K | |
| 2023 | 86,835 | $339K | |
| 2024incomplete | 101,026 | $262K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0510 | 59% | 10,538 | 9,359 | $764K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 8.1% | 5,520 | 3,764 | $105K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6.5% | 27,278 | 13,045 | $85K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.2% | 37,413 | 15,640 | $55K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.3% | 669 | 601 | $30K |
| 76770 | 2.2% | 1,108 | 1,094 | $28K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.7% | 11,355 | 4,818 | $22K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 2,026 | 1,846 | $20K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,589 | 1,769 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 5,597 | 5,043 | $9K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 5,712 | 3,118 | $8K |
| 97167 | <1% | 1,922 | 1,776 | $8K |
207 more codes
| 98960 | <1% | 3,616 | $8K | |
| 80061 | Lipid panel | <1% | 3,389 | $7K |
| 51705 | <1% | 105 | $6K | |
| 0760 | <1% | 297 | $6K | |
| 73564 | <1% | 2,401 | $6K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 4,003 | $6K |
| 92523 | <1% | 1,636 | $6K | |
| 97162 | <1% | 5,090 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,361 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,856 | $5K |
| 97542 | <1% | 2,940 | $5K | |
| 98968 | <1% | 2,033 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,380 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 8,608 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,693 | $4K |
| 97161 | <1% | 3,671 | $4K | |
| 97116 | <1% | 2,774 | $4K | |
| 52287 | <1% | 46 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,502 | $3K |
| 73562 | <1% | 1,326 | $3K | |
| 92550 | <1% | 458 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,750 | $3K |
| 92557 | <1% | 983 | $3K | |
| 97163 | <1% | 641 | $3K | |
| 92227 | <1% | 2,023 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,889 | $2K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,862 | $2K |
| Q3014 | Telehealth originating site facility fee | <1% | 253 | $2K |
| 74018 | <1% | 1,211 | $2K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,836 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,324 | $2K |
| 90889 | <1% | 3,706 | $2K | |
| 86703 | <1% | 712 | $1K | |
| 87186 | <1% | 1,014 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 23,476 | $1K |
| 97166 | <1% | 1,726 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,365 | $1K |
| 90885 | <1% | 725 | $1K | |
| 92015 | Determination of refractive state | <1% | 877 | $1K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 8,182 | $938.09 |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 6,678 | $923.35 |
| 85610 | <1% | 3,003 | $895.81 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 46,857 | $831.74 |
| 85027 | <1% | 823 | $746.47 | |
| 73630 | <1% | 888 | $722.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,136 | $594.10 |
| 77073 | <1% | 658 | $554.46 | |
| 98967 | <1% | 2,141 | $554.27 | |
| 86480 | <1% | 196 | $551.49 | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,736 | $539.83 |
| 73522 | <1% | 381 | $535.82 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 5,887 | $518.07 |
| 81001 | <1% | 3,783 | $509.75 | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 287 | $488.62 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 462 | $430.37 |
| 86141 | <1% | 302 | $383.57 | |
| 20610 | <1% | 435 | $368.44 | |
| 90750 | <1% | 663 | $364.42 | |
| 82043 | <1% | 879 | $364.03 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 556 | $318.11 |
| 97113 | <1% | 349 | $304.01 | |
| 85730 | <1% | 185 | $297.42 | |
| 92250 | <1% | 133 | $280.29 | |
| 84439 | <1% | 169 | $257.93 | |
| 95816 | <1% | 13 | $248.06 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 425 | $237.05 |
| 93247 | <1% | 277 | $215.76 | |
| 82274 | <1% | 3,592 | $206.94 | |
| 87522 | Neg quan hep c or qual rna | <1% | 484 | $194.99 |
| 82540 | <1% | 1,127 | $186.79 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 109 | $173.82 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 8,855 | $169.89 |
| 85652 | <1% | 293 | $164.57 | |
| 93971 | <1% | 111 | $164.45 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 26 | $140.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,280 | $136.73 |
| 99443 | <1% | 6,887 | $126.00 | |
| 73030 | <1% | 63 | $122.83 | |
| 99442 | <1% | 16,475 | $120.13 | |
| 72040 | <1% | 53 | $116.30 | |
| 87088 | <1% | 797 | $113.64 | |
| 83540 | <1% | 54 | $110.23 | |
| 92526 | <1% | 181 | $104.79 | |
| 80305 | <1% | 274 | $84.40 | |
| 97032 | <1% | 203 | $80.79 | |
| 84153 | <1% | 27 | $67.56 | |
| 73521 | <1% | 14 | $63.73 | |
| 98966 | <1% | 375 | $63.09 | |
| 88142 | <1% | 258 | $59.99 | |
| 83735 | <1% | 13 | $48.20 | |
| 81003 | <1% | 423 | $44.69 | |
| 99441 | <1% | 3,282 | $40.64 | |
| 86901 | <1% | 98 | $38.70 | |
| 92610 | <1% | 57 | $38.30 | |
| 92002 | <1% | 14 | $37.02 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 556 | $34.10 |
| 82565 | <1% | 116 | $29.87 | |
| 0771 | <1% | 1,946 | $29.52 | |
| 82728 | <1% | 14 | $26.98 | |
| 83550 | <1% | 28 | $25.95 | |
| 86850 | <1% | 25 | $25.78 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 24,033 | $25.65 |
| 94770 | <1% | 517 | $25.00 | |
| 82607 | <1% | 121 | $24.17 | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 367 | $21.52 |
| 93970 | <1% | 44 | $21.50 | |
| 85008 | <1% | 27 | $20.40 | |
| 86900 | <1% | 13 | $17.43 | |
| 0250 | <1% | 212 | $16.92 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 422 | $14.29 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 249 | $13.49 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,450 | $13.34 |
| 92134 | <1% | 197 | $11.49 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,156 | $8.92 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 553 | $8.91 |
| 81025 | <1% | 176 | $4.50 | |
| 97165 | <1% | 48 | $0.81 | |
| 82962 | <1% | 656 | $0.34 | |
| 99205 | Prolong outpt/office vis | 0% | 1,159 | $0.00 |
| 73560 | 0% | 96 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 744 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,322 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 1,334 | $0.00 |
| 99024 | 0% | 244 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 433 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 931 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 1,340 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 431 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 455 | $0.00 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 0% | 256 | $0.00 |
| 3075F | 0% | 1,309 | $0.00 | |
| 0100 | 0% | 559 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 384 | $0.00 |
| 0636 | 0% | 1,967 | $0.00 | |
| 3052F | 0% | 231 | $0.00 | |
| 1111F | 0% | 3,296 | $0.00 | |
| 3074F | 0% | 3,925 | $0.00 | |
| 3079F | 0% | 1,136 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 1,129 | $0.00 |
| 93294 | 0% | 75 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 27 | $0.00 |
| 90677 | 0% | 242 | $0.00 | |
| 3080F | 0% | 402 | $0.00 | |
| 3044F | 0% | 2,761 | $0.00 | |
| 92587 | 0% | 13 | $0.00 | |
| 90723 | 0% | 27 | $0.00 | |
| 93797 | 0% | 165 | $0.00 | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 0% | 57 | $0.00 |
| 90656 | 0% | 487 | $0.00 | |
| 87081 | 0% | 73 | $0.00 | |
| 99386 | 0% | 131 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 26 | $0.00 |
| 90887 | 0% | 14 | $0.00 | |
| 95992 | 0% | 12 | $0.00 | |
| 94010 | 0% | 15 | $0.00 | |
| 81015 | 0% | 118 | $0.00 | |
| 99243 | 0% | 13 | $0.00 | |
| 98961 | 0% | 25 | $0.00 | |
| 95851 | 0% | 16 | $0.00 | |
| 90651 | 0% | 15 | $0.00 | |
| 90686 | 0% | 910 | $0.00 | |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | 0% | 12 | $0.00 |
| 99385 | 0% | 13 | $0.00 | |
| 1220F | 0% | 13 | $0.00 | |
| 91300 | 0% | 584 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,264 | $0.00 |
| 3078F | 0% | 4,725 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 1,091 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 401 | $0.00 |
| 93017 | 0% | 93 | $0.00 | |
| 93798 | 0% | 1,400 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 249 | $0.00 |
| 0300 | 0% | 544 | $0.00 | |
| 3051F | 0% | 413 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 715 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 280 | $0.00 |
| 72100 | 0% | 141 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 770 | $0.00 |
| 90648 | 0% | 58 | $0.00 | |
| 3046F | 0% | 397 | $0.00 | |
| 99201 | 0% | 58 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 108 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 129 | $0.00 |
| 90670 | 0% | 16 | $0.00 | |
| 31502 | 0% | 59 | $0.00 | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 0% | 475 | $0.00 |
| 3077F | 0% | 1,443 | $0.00 | |
| 73523 | 0% | 13 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 45 | $0.00 |
| 87338 | 0% | 59 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
| 0120 | 0% | 2,262 | $0.00 | |
| 90653 | 0% | 81 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 127 | $0.00 |
| 92083 | 0% | 13 | $0.00 | |
| 43762 | 0% | 27 | $0.00 | |
| 90714 | 0% | 54 | $0.00 | |
| S5551 | Insulin, most rapid onset (lispro or aspart); 5 units | 0% | 316 | $0.00 |
| 73610 | 0% | 14 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 12 | $0.00 |
| 97164 | 0% | 18 | $0.00 | |
| 91312 | 0% | 16 | $0.00 | |
| 0124A | 0% | 16 | $0.00 | |
| 0731 | 0% | 13 | $0.00 | |
| 84100 | 0% | 12 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 152 | $0.00 |
| 92133 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIMBAGA, ARIES (CEO)
Parent organizationCOUNTY OF LOS ANGELES